More on PPCB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings

Upcoming Events

- Earnings (1/2/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Propanc Biopharma, Inc. (NQ:PPCB)
Delayed: 1.47 -0.04 (2.65%)
Prev. Close $1.51  
Open$1.43 
52 Wk High$ 
52 Wk Low$ 
Day High$1.50 
Day Low$1.41 
P/E N/A  
EPS$ 
Volume53,783 


Jun 16, 2026 08:45 AM PROPANC Biopharma CEO visits European CDMO for PRP drug production
Jun 16, 2026 08:45 AM PPCB CEO visits European CDMO ahead of PRP drug manufacturing plan
Jun 16, 2026 08:45 AM Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study
Jun 16, 2026 08:45 AM Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study
Jun 11, 2026 08:30 AM Propanc Biopharma authorizes $5 million stock buyback program
Jun 11, 2026 08:30 AM Propanc Biopharma Authorizes $5.0 Million Share Repurchase Program
Jun 2, 2026 05:30 AM Propanc Biopharma’s CEO Attends Keynote Address, “Rejuvenation and Health: Science for an Ageing Society,” at the University of Granada, Spain
May 20, 2026 08:45 AM Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade
May 19, 2026 08:45 AM Propanc Biopharma engages European manufacturer for cancer drug trial
May 19, 2026 08:45 AM Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients
View All Articles

Entities mentioned with PPCB

View All Entities